4//SEC Filing
Ignelzi Troy A. 4
Accession 0000950170-25-038878
CIK 0002012593other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:13 PM ET
Size
5.8 KB
Accession
0000950170-25-038878
Insider Transaction Report
Form 4
Ignelzi Troy A.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2025-03-13$9.98/sh+100$998→ 10,000 total - Purchase
Common Stock
2025-03-12$10.10/sh+9,900$99,990→ 9,900 total
Documents
Issuer
Rapport Therapeutics, Inc.
CIK 0002012593
Entity typeother
Related Parties
1- filerCIK 0001579829
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 5:13 PM ET
- Size
- 5.8 KB